Richard Paulson - Insider Trading & Ownership

Entity
Individual
Location
85 Wells Avenue, Newton, MA
Summary
The estimated net worth of Richard Paulson is at least $2.23M dollars as of September 5, 2024. Richard Paulson is the President and CEO, Director of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $2.22M. Richard Paulson is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. (BLUE) stock worth about $6.67K.
All Insider Reports
All Insider Reports

Ownership of Richard Paulson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. President and CEO, Director $2.22M -$159K -6.69% Sep 4, 2024
BLUE bluebird bio, Inc. Director $6.67K Apr 3, 2023

Insider Transactions Reported by Richard Paulson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.